Cover Image
Market Research Report

Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market 2019-2023

Published by TechNavio (Infiniti Research Ltd.) Product code 825223
Published Content info 114 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market 2019-2023
Published: March 27, 2019 Content info: 114 Pages
Description

About this market

The significant advances in their healthcare infrastructure and technological advances in their drug development processes. As a result, large and medium-sized pharmaceutical companies from developed countries are outsourcing the research and manufacturing operations of various drugs and therapies to the vendors in such countries. Factors such as the increasing number of US FDA-approved manufacturing plants in such countries also encourage outsourcing. The rapidly evolving market environment and the strong support of the Government of China help the country specialize in the research of drugs, including regenerative medicines and small-molecule based drugs. Therefore, the global pharmaceutical CRAM market is expected to grow strongly during the forecast period. Technavio's analysts have predicted that the pharmaceutical contract research and manufacturing (CRAM) market will register a CAGR of more than 9% by 2023.

Market Overview

Growing need to focus on core competencies

One of the growing changes in the global pharmaceutical market is the increasing volume of outsourcing of partial or complete research and manufacturing processes to CROs and CMOs. This is primarily due to the rising focus of the sourcing companies on developing therapies for large indications such as oncology, neurology, and autoimmune disorders.

Stereotypical nature of CMOs

Despite the growing popularity of CMOs in emerging countries such as China and India, the global pharmaceutical CRAM market faces a major challenge from the limited offerings of the CMOs. This is currently a major challenge faced by CMOs, which is expected to significantly hinder the growth of the global pharmaceutical CRAM market during the forecast period.

For the detailed list of factors that will drive and challenge the growth of the pharmaceutical contract research and manufacturing (CRAM) market during the 2019-2023, view our report.

Competitive Landscape

The market appears to be moderately concentrated and with the presence of limited vendors. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

Table of Contents
Product Code: IRTNTR31081

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY SERVICE

  • Market segmentation by service
  • Comparison by service
  • CMO - Market size and forecast 2018-2023
  • CRO - Market size and forecast 2018-2023
  • Market opportunity by service

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 10: MARKET TRENDS

PART 11: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 12: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Boehringer Ingelheim International GmbH
  • Catalent, Inc
  • IQVIA
  • Lonza
  • Thermo Fisher Scientific Inc.

PART 13: APPENDIX

  • Research methodology
  • List of abbreviations

List of Exhibits

  • Exhibit 01: Global pharmaceuticals market
  • Exhibit 02: Segments of global pharmaceuticals market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2018
  • Exhibit 07: Global market: Size and forecast 2018-2023 ($ billions)
  • Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 09: Five forces analysis 2018
  • Exhibit 10: Five forces analysis 2023
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2018
  • Exhibit 17: Service - Market share 2018-2023 (%)
  • Exhibit 18: Comparison by service
  • Exhibit 19: CMO - Market size and forecast 2018-2023 ($ billions)
  • Exhibit 20: CMO - Year-over-year growth 2019-2023 (%)
  • Exhibit 21: CRO - Market size and forecast 2018-2023 ($ billions)
  • Exhibit 22: CRO - Year-over-year growth 2019-2023 (%)
  • Exhibit 23: Market opportunity by service
  • Exhibit 24: Customer landscape
  • Exhibit 25: Market share by geography 2018-2023 (%)
  • Exhibit 26: Geographic comparison
  • Exhibit 27: North America - Market size and forecast 2018-2023 ($ billions)
  • Exhibit 28: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 29: Top 3 countries in North America
  • Exhibit 30: Asia - Market size and forecast 2018-2023 ($ billions)
  • Exhibit 31: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 32: Top 3 countries in Asia
  • Exhibit 33: Europe - Market size and forecast 2018-2023 ($ billions)
  • Exhibit 34: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 35: Top 3 countries in Europe
  • Exhibit 36: ROW - Market size and forecast 2018-2023 ($ billions)
  • Exhibit 37: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 38: Top 3 countries in ROW
  • Exhibit 39: Key leading countries
  • Exhibit 40: Market opportunity
  • Exhibit 41: Impact of drivers and challenges
  • Exhibit 42: Vendor landscape
  • Exhibit 43: Landscape disruption
  • Exhibit 44: Vendors covered
  • Exhibit 45: Vendor classification
  • Exhibit 46: Market positioning of vendors
  • Exhibit 47: Boehringer Ingelheim International GmbH - Vendor overview
  • Exhibit 48: Boehringer Ingelheim International GmbH - Business segments
  • Exhibit 49: Boehringer Ingelheim International GmbH - Organizational developments
  • Exhibit 50: Boehringer Ingelheim International GmbH - Geographic focus
  • Exhibit 51: Boehringer Ingelheim International GmbH - Segment focus
  • Exhibit 52: Boehringer Ingelheim International GmbH - Key offerings
  • Exhibit 53: Boehringer Ingelheim International GmbH - Key customers
  • Exhibit 54: Catalent, Inc - Vendor overview
  • Exhibit 55: Catalent, Inc - Business segments
  • Exhibit 56: Catalent, Inc - Organizational developments
  • Exhibit 57: Catalent, Inc - Geographic focus
  • Exhibit 58: Catalent, Inc - Segment focus
  • Exhibit 59: Catalent, Inc - Key offerings
  • Exhibit 60: Catalent, Inc - Key customers
  • Exhibit 61: IQVIA - Vendor overview
  • Exhibit 62: IQVIA - Business segments
  • Exhibit 63: IQVIA - Organizational developments
  • Exhibit 64: IQVIA - Geographic focus
  • Exhibit 65: IQVIA - Segment focus
  • Exhibit 66: IQVIA - Key offerings
  • Exhibit 67: IQVIA - Key customers
  • Exhibit 68: Lonza - Vendor overview
  • Exhibit 69: Lonza - Business segments
  • Exhibit 70: Lonza - Organizational developments
  • Exhibit 71: Lonza - Geographic focus
  • Exhibit 72: Lonza - Segment focus
  • Exhibit 73: Lonza - Key offerings
  • Exhibit 74: Lonza - Key customers
  • Exhibit 75: Thermo Fisher Scientific Inc. - Vendor overview
  • Exhibit 76: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 77: Thermo Fisher Scientific Inc. - Organizational developments
  • Exhibit 78: Thermo Fisher Scientific Inc. - Geographic focus
  • Exhibit 79: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibit 80: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 81: Thermo Fisher Scientific Inc. - Key customers
  • Exhibit 82: Validation techniques employed for market sizing
Back to Top